Lapides Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Lapides Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-186,200	Closed	-$2.04M	–	94
2017 Q3	$2.04M	Hold	186,200	–	–	0.42%	62
2017 Q2	$2.04M	Sell	186,200 -210,600	-53%	-$2.31M	0.39%	58
2017 Q1	$4.19M	Hold	396,800	–	–	0.79%	41
2016 Q4	$3.33M	Buy	396,800 +70,000	+21%	+$549K	0.6%	50
2016 Q3	$2.34M	Buy	326,800 +36,400	+13%	+$253K	0.4%	57
2016 Q2	$2.23M	Buy	290,400 +6,400	+2%	+$45.6K	0.41%	55
2016 Q1	$2.08M	Buy	284,000 +46,200	+19%	+$331K	0.37%	59
2015 Q4	$1.83M	Buy	237,800 +161,200	+210%	+$1.23M	0.32%	68
2015 Q3	$548K	Buy	+76,600	New	+$736K	0.09%	83

Lapides Asset Management's ELOS Position: Q4 2017 in Review

Lapides Asset Management sold out of Syneron Medical Ltd (ELOS) in Q4 2017, closing a stake of 186,200 shares — an estimated $2.04M sold.

Lapides Asset Management first reported a position in ELOS in Q3 2015 and held it in 9 quarters. The position peaked at $4.19M in Q1 2017. 1 fund tracked by Wall St. Rank holds ELOS as of Q4 2017.

Lapides Asset Management reported no remaining Syneron Medical Ltd position as of Q4 2017 after selling out during the quarter.
Lapides Asset Management sold 186,200 Syneron Medical Ltd shares in Q4 2017, an estimated $2.04M.
Lapides Asset Management first reported a position in Syneron Medical Ltd in Q3 2015 and held it in 9 quarters.
Lapides Asset Management's Syneron Medical Ltd position peaked at $4.19M in Q1 2017.
1 fund tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2017.

Based on Lapides Asset Management's 13F filing for Q4 2017, filed 8 Feb 2018.